Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease. - Wikidata - awgldk - TriplyDB

Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease.

Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease.

http://www.wikidata.org/entity/Q33391049

about

Occult peripheral artery disease is common and limits the benefit achieved in cardiac rehabilitation.The cost-effectiveness of exercise-based cardiac rehabilitation: a systematic review of the characteristics and methodological quality of published literature.

P2860

Q38911555-E24E8CA0-D04B-4CD2-BB10-B07ECE4D9353 Q45401407-1113072E-7FEB-4CDE-932D-14E5A4C2F6DA

P2860

Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease.

http://www.wikidata.org/entity/Q33391049

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cost-effectiveness of new card ...... with coronary artery disease.

@ast

Cost-effectiveness of new card ...... with coronary artery disease.

@en

type

label

Cost-effectiveness of new card ...... with coronary artery disease.

@ast

Cost-effectiveness of new card ...... with coronary artery disease.

@en

prefLabel

Cost-effectiveness of new card ...... with coronary artery disease.

@ast

Cost-effectiveness of new card ...... with coronary artery disease.

@en

P1433

Q33391049-26019BB1-D940-435E-8A5C-04FAB7364C72

P1476

Q33391049-958CC8E0-C4E6-40FD-8FB0-58B5E317ADA5

P2093

Q33391049-2E001E46-1162-4300-B1B4-A03288055F20

Q33391049-4659E2D4-D0C9-42DA-B046-AF54893CAC9C

Q33391049-7DDE7114-EB60-451C-A869-5F1D970B0315

Q33391049-A24D6465-F2B8-49AF-911B-1063F056BA56

Q33391049-CD5436EF-FBCC-4298-91DE-37A78EF78416

Q33391049-E56FC9DB-D5FB-4A47-A74A-62948DF011ED

Q33391049-F180A141-7B8D-4463-9FEB-D842FF8125C0

P2860

Q33391049-06132700-86AF-4DAC-A61D-8BA6BCB8F95A

Q33391049-087B2004-7EBE-4EAA-981D-32FB5E08BC03

Q33391049-0F2A691C-0965-4132-99E7-558A2C7B8C5D

Q33391049-107B02AE-3597-458F-B81A-73012AB4C74A

Q33391049-11CD642E-C4E8-48F0-A2EF-482F9484B515

Q33391049-143E8E44-3745-4A0A-95E9-DCEE4B613A37

Q33391049-19F7656A-0F58-47A0-8A0F-D5E4907B181A

Q33391049-215A40D7-0941-4F53-B7DA-0D2342C797C3

Q33391049-2471A3D1-09DE-4821-A7B4-CF868E6F4F2B

Q33391049-2549C844-7A11-465F-8AEE-4DEAED3273E2

P304

Q33391049-7F819481-8738-4ECB-AC2D-B92076BC650E

P31

Q33391049-DD85A783-7D24-428A-929B-C5F52913E137

P356

Q33391049-7AB43C71-0C58-43F6-81B5-9D2C6D1EB6CC

P407

Q33391049-90939E5B-7C0D-4E77-9A6C-8592203E8056

P433

Q33391049-77258B61-5DFB-4B33-BFC9-F1E4E6C27316

P478

Q33391049-E09EE30E-315F-4420-A11A-1F582E36A589

P577

Q33391049-B0376EF0-4DD1-4614-BF4B-6A28AF54C8CB

P5875

Q33391049-FC0DE4C1-B2C5-494B-91EE-0EAFC651D8C6

P698

Q33391049-7F45E566-8338-4CE9-B9C5-B0DAD2B8F935

P932

Q33391049-762933A8-11EA-4D9E-A3B9-6D9EE4350627

P356

JOURNAL.PONE.0003883

P1433

P1476

Cost-effectiveness of new card ...... with coronary artery disease.

@en

P2093

Constance Ryjewski

http://www.w3.org/2001/XMLSchema#string

Guido C Kaandorp

http://www.w3.org/2001/XMLSchema#string

Johanna L Bosch

http://www.w3.org/2001/XMLSchema#string

John V White

http://www.w3.org/2001/XMLSchema#string

Judith Rosenblum

http://www.w3.org/2001/XMLSchema#string

M G Myriam Hunink

http://www.w3.org/2001/XMLSchema#string

Sandra Spronk

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine.

Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme.

Validation of the EuroQol questionnaire in cardiac rehabilitation

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

Subintimal angioplasty: Our experience in the treatment of 506 infrainguinal arterial occlusions.

Arteriographic complications in the DSA era.

Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.

The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys.

P304

e3883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0003883

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23640628

http://www.w3.org/2001/XMLSchema#string

P698

19065259

http://www.w3.org/2001/XMLSchema#string

P932

2587698

http://www.w3.org/2001/XMLSchema#string